CD14 and Behcet disease: The IL-6 increase was significantly lower in the treated groups compared to the BD group: C5 inhibition group 924 pg/mL (443–1407) (p = 0.016), CD-14 inhibition group 327 pg/mL (141–513) (p = 0.010) and the dual treatment group 825 pg/mL (-93-1744) (p = 0.015) (Fig. 1A).